Godavari Drugs Ltd. Promoter Acquires Convertible Warrants
Godavari Drugs Limited announced that Sushma Kakani, a promoter of the company, has acquired 4,23,000 convertible warrants through a preferential issue on March 18, 2026.According to a regulatory filing, Kakani’s acquisition of the warrants increases their holdings. Prior to the acquisition, Kakani held 11,55,000 shares representing 15.34% of the company's total share capital and 15.31% of the diluted share capital.
Following the acquisition of 4,23,000 warrants, Kakani’s total holdings now stand at 15,78,000, which translates to 11.40% and 12.04% of the total and diluted share capital respectively.
Godavari Drugs Limited has an equity share capital of Rs. 7,53,05,000 divided into 75,30,500 fully paid-up equity shares of Rs. 10 each. The company’s equity share capital following the acquisition is Rs. 10,12,74,350 divided into 1,01,27,43 equity shares of Rs. 10 each, and the total diluted share/voting capital is Rs. 12,48,75,000 divided into 1,24,87,500 fully paid-up equity shares of Rs. 10 each.
| Detail | Value |
|---|---|
| Convertible Warrants Acquired | 4,23,000 |
| Date of Acquisition | March 18, 2026 |
| Total Share Capital | Rs. 7,53,05,000 |
| Total Diluted Share/Voting Capital | Rs. 12,48,75,000 |
| BSE Scrip Code | 530317 |
Source:
Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.